USD 73.69 million
Cholera Vaccines Market Size, Share, Growth Analysis, By End user(Hospitals, specialty clinics, research and academic laboratories and pharmaceutical and biotechnology companies and others), By Type(Dukoral, Shanchol, Vaxchora, Euvichol), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35I2103 |
Region:
Global |
Published Date: July, 2024
Pages:
219
|Tables:
65
|Figures:
75
Cholera Vaccines Market Insights
Global Cholera Vaccines Market was valued at USD 73.69 million in 2022, and is expected to rise from USD 79.07 million in 2023 to reach a value of USD 138.93 million by 2031, rising at a CAGR of 7.30 % during the forecast period 2024-2031.
Tainted food and water transmit the bacterial infections that cause cholera and affect the intestines. In addition to muscle cramps and dry mucous membranes like those on the inside of the mouth, throat, nose, and eyelids, it causes severe diarrhea, dehydration, abdominal pain, fever, a quick heartbeat, loss of skin elasticity, low blood pressure, and rapid heart rate. Currently, it threatens public health globally, but vaccination can stop it. The cholera vaccine exposes the body to a small number of live cholera bacteria, aiding in the development of immunity. It can be administered intravenously, intramuscularly, or orally. A biological preparation known as a vaccine helps the immune system develop and gives immunity to specific infectious illnesses. Many international institutions, like the World Health Organization, employ vaccines to treat infectious diseases (WHO). One contagious sickness known as cholera is brought on by consuming food or water tainted with the vibrio cholera bacterium. The infection is characterized by profuse watery diarrhea and has a brief incubation period of a few hours to five days. Sometimes cholera can be lethal. The disease is intimately associated with unhygienic behavior, inadequate sanitization, and a lack of safe drinking water. It occurs in both endemic and epidemic patterns.
US Cholera Vaccines Market is poised to grow at a sustainable CAGR for the next forecast year.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Dukoral
Fastest Growth
Dukoral
Growth Rate
7.30% CAGR
Global Cholera Vaccine Market, 2024-2031 ($ Bn)
Country Share for Asia Pacific Region- 2024 (%)
To get more reports on the above market click here to Buy The Report
Cholera Vaccines Market Segmental Analysis
Cholera Vaccines Market is divided on the basis of product type, administration route, end-users, channel of distribution, and regions. On the basis of type, the cholera vaccines market is segmented into dukoral, euvichol, and shanchol. On the basis of route of administration, the Cholera Vaccines Market is divided into oral. On the basis of end-users, the Cholera Vaccines Market is grouped into specialty clinics, hospitals, research & academic laboratories, pharmaceutical & biotechnology companies, and others. On the basis of distribution channel, the cholera vaccines market has also been segmented into hospital pharmacy, retail pharmacy and others.
Cholera Vaccines Market Analysis by Type
Based on classification by type,, the market is divided into Dukoral, Shanchol, Vaxchora, Euvichol, and others, with the Dukoral segment holding the largest market share. The segment's growth can be attributed primarily to the availability of a significant volume of this product as stockpiled by the WHO, as well as the high demand for these vaccines among international travellers, the volume of which is rapidly increasing in low- and middle-income countries. This segment is further projected to continue dominating the market in the near future.
Cholera Vaccines Market Analysis by End User
As per classification by end user, the market is segmented into hospitals, specialty clinics, research and academic laboratory and pharmaceutical and biotechnology companies and others. Research and academic laboratories segment is projected to exhibit the highest growth during the forecast period. This is attributed to the rise in demand for cholera vaccine across the world. Thus, helps in increasing the cholera vaccine market size in the near future.
Global Cholera Vaccine Market By Type
To get detailed analysis on other segments, Request For Free Sample Report
Cholera Vaccines Market Regional Insights
The market is segmented into North America, Europe, Asia Pacific, Latin America and the Middle East and Africa (MEA). According to regional analysis, Asia-Pacific has the largest market share. This is due to increased access to effective preventive measures, rise in public awareness of the disease, and the disease's high incidence rate. Europe is also expected to grow steadily during the forecast period, owing to the region's well-established healthcare infrastructure. North America, on the other hand, is expected to grow at a faster rate during the forecast period, owing to rising consumption of contaminated food, a lack of appropriate hygiene, and an increasing number of migrants. At the same time, increased R&D activities, rising public awareness of vaccination, and rising government initiatives to conduct immunisation programmes would all contribute to the growth of the cholera vaccine market in this region.
Global Cholera Vaccine Market By Region
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Cholera Vaccines Market Dynamics
Cholera Vaccines Market Drivers
Unhealthy Lifestyles and Poor Sanitation Issues to Prevail in Cholera
- The development of creative methods to new cholera vaccines, increased awareness of cholera preventative care, and adoption of unhealthy lifestyle habits including poor sanitation and consumption of tainted food are the factors anticipated to propel the growth of the cholera vaccines market. Additionally, a greater focus on immunisation campaigns by the government has fueled the market expansion for cholera vaccines. The global cholera vaccines market, however, may be hindered by the FDA's stricter criteria and longer approval process for new drugs.
- One of the major factors driving the market is the increasing prevalence of cholera due to poor hygiene and sanitation. Furthermore, there is an increase in the use of contaminated water for agriculture and olericulture around the world. This, combined with an increase in consumption of street and fast food due to people's hectic lifestyles, is propelling the market's growth.
Cholera Vaccines Market Restraints
Longer Production Time for Cholera Vaccines may Hamper Growth
- The long development time for vaccines and the presence of stringent regulatory approvals are likely to limit market growth during the forecast period.
- Vaccine production is a time-consuming and expensive process. Furthermore, cholera vaccines may have a number of negative side effects on human health. Simultaneously, regulatory approvals for specific vaccines take a long time. These factors are expected to limit the growth of the cholera vaccine market in the coming years.
Request Free Customization of this report to help us to meet your business objectives.
Cholera Vaccines Market Competitive Landscape
The report provides a detailed analysis of the following key players in the global cholera vaccines market, including their competitive landscape, capacity, and most recent developments such as mergers, acquisitions, and investments, capacity expansions, and plant turnarounds. The presence of
Cholera Vaccines Market Top Player's Company Profiles
- Sanofi S.A.
- GlaxoSmithKline plc
- PaxVax Inc. (now part of Emergent BioSolutions)
- Bharat Biotech
- Medtronics
- EuBiologics Co. Ltd.
- Shantha Biotechnics Private Limited (part of Sanofi Pasteur)
- Bio Farma (Indonesia Vaccine Institute)
- Eubiologics Co. Ltd.
- Merck & Co., Inc.
- Cipla Limited
- Astellas Pharma Inc.
- Takeda Pharmaceutical Company Limited
- Panacea Biotec Ltd.
- Serum Institute of India Pvt. Ltd.
- Beijing Minhai Biotechnology Co. Ltd.
- Biken Corporation
- OCV Consortium (The Bill and Melinda Gates Foundation, WHO, and others)
- PaxVax Bermuda Ltd.
- GSK Biologicals SA.
Cholera Vaccines Market Recent Developments
-
In May 2023, the International Vaccine Institute (IVI) began clinical development of DuoChol, a new low-cost oral cholera vaccine (OCV) in capsule form. With funding support from the Wellcome Trust and the Swedish government, IVI is preparing to conduct a Phase I clinical trial of the vaccine in Sweden.
-
In February 2023, Bavarian Nordic completed the acquisition of Emergent BioSolutions’ travel vaccine portfolio for an upfront payment of $274million, with the potential for the total value to rise to $384million. The deal encompasses Vivotif and Vaxchora, both marketed vaccines for the prevention of typhoid fever and cholera respectively, and a Phase III vaccine candidate for the prevention of Chikungunya virus, which have now all been transferred to Bavarian Nordic.
-
In November 2022, South Africa's Biovac Institute signed a licensing and technology transfer deal with the International Vaccine Institute (IVI) to develop and make oral cholera vaccine for African and global markets.
Cholera Vaccines Key Market Trends
- The global market is primarily driven by the increasing prevalence of cholera among the general population. This is due to poor sanitation and hygiene conditions in rural and geographically remote areas. Furthermore, rising public awareness of the availability of cholera vaccines has boosted product demand.
- Increasing investments and funding by public and private agencies for extensive research and development (R&D) activities are also having a positive impact on the market. Other factors influencing market growth include rising healthcare spending, a significant increase in water pollution, and an increase in the number of research laboratories and diagnostic centres.
Cholera Vaccines Market SkyQuest Analysis
SkyQuest’s ABIRAWA (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected utilizing Primary Exploratory Research backed by the robust Secondary Desk research.
According to our analysis, The market for cholera vaccines is anticipated to increase significantly during the forecast period as a result of rising venous disease prevalence and rising new product approvals to meet this need. The market is expected to develop as a result of rising disease awareness, growing value of early detection, and rising spending on chronic illnesses. Additionally, the major market participants are spending money on the development of technologically improved goods, which will expand the use of cholera vaccines in both developed and developing nations.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 73.69 million |
| Market size value in 2031 | USD 138.93 million |
| Growth Rate | 7.30% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Cholera Vaccines Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Cholera Vaccines Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Cholera Vaccines Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Cholera Vaccines Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Cholera Vaccines Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Cholera Vaccines Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
